NVS Novartis AG

NYSE
$150.88

Novartis AG (NVS) is expected to report earnings on October 20, 2026, before the market open. The consensus earnings estimate is $2.24 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -2.9% since its last earnings release on July 21, 2026.

Novartis AG Beat Consensus Estimates
Tuesday, July 21, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 20
Tuesday · Before Open
Earnings Whisper
-
vs $2.24
Rev est $14.37B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $155.00

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Novartis AG

Novartis AG is engaged in the research, development, manufacturing and marketing of healthcare products and pharmaceuticals.

Sector

Healthcare

Industry

Drug Manufacturers / Major

Held By 1 ETFs, by dollar flow